The global weight loss supplement market size is estimated to grow by USD 1.53 billion from 2024-2028, according to Technavio ...

Ardelyx faces headwinds from emerging GLP-1 weight loss drugs, potentially reducing ... The company's high valuation looks ...

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Weight Loss Drugs Market- ...

China has approved Novo Nordisk A/S’s blockbuster Wegovy for chronic weight management, opening up competition for next-generation obesity drugs in the world’s second-largest economy.China’s National ...

Zuo Ya-Jun, general manager of weight loss drugmaker Shanghai Benemae Pharmaceutical, said a product being competitive would depend on distinguishing features such as efficacy, durability of the t ...

"Leveraging our strong partnerships, we offer a range of GLP-1 medications directly sourced from the leading pharmaceutical ...

For many athletes, intense training and meticulous preparation are the building blocks of success in sports tournaments.

Novo Nordisk's weight loss drug Wegovy has received approval in China, representing a notable achievement for the Danish ...

The competitive landscape and regulatory challenges ... are not worried about the impact of weight-loss drugs on their ice cream business, despite the impending spin-off of their parent company ...

“Weight-loss drugs fall within a market with massive growth potential in China.” Von Mehren said the rising demand means that competition between suppliers will not be a major obstacle in the ...

The global automotive batteries market size is estimated to grow by USD 119.8 billion from 2024-2028, according to Technavio.